262 related articles for article (PubMed ID: 29483954)
1. Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.
Ning S; Wei W; Li J; Hou B; Zhong J; Xie Y; Liu H; Mo X; Chen J; Zhang L
J Cancer; 2018; 9(3):494-501. PubMed ID: 29483954
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.
Singh S; Kumar R; Kumar U; Kumari R
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667
[TBL] [Abstract][Full Text] [Related]
3. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
[TBL] [Abstract][Full Text] [Related]
8. Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers.
Wang CX; Zhuang HB; Shi ZS; Qiu CZ; Chen ZX; Tang LF
Dis Markers; 2021; 2021():8880282. PubMed ID: 33680216
[TBL] [Abstract][Full Text] [Related]
9. Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.
Luo H; Shen K; Sun H; Li R; Wang Z; Xie Z
Medicine (Baltimore); 2020 Apr; 99(16):e19796. PubMed ID: 32311993
[TBL] [Abstract][Full Text] [Related]
10. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
[TBL] [Abstract][Full Text] [Related]
11. Clinical Value on Combined Detection of Serum CA724, DKK1, and TK1 in Diagnosis of Gastric Cancer.
Wang Y; Cui D; Li D; Li D; Wang H; Wu Y
J Oncol; 2022; 2022():6941748. PubMed ID: 36276284
[TBL] [Abstract][Full Text] [Related]
12. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
[No Abstract] [Full Text] [Related]
14. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
15. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer.
Kumamoto K; Ishida H; Kuwabara K; Amano K; Chika N; Okada N; Ohsawa T; Kumagai Y; Ishibashi K
Mol Clin Oncol; 2017 Oct; 7(4):595-600. PubMed ID: 28855992
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics.
Tomašević R; Milosavljević T; Stojanović D; Gluvić Z; Dugalić P; Ilić I; Vidaković R
J Med Biochem; 2016 Sep; 35(3):324-332. PubMed ID: 28356884
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?
Kotzev AI; Draganov PV
Gastrointest Tumors; 2018 Sep; 5(1-2):1-13. PubMed ID: 30574476
[TBL] [Abstract][Full Text] [Related]
19. Application Value of Serum TK1 and PCDGF, CYFRA21-1, NSE, and CEA plus Enhanced CT Scan in the Diagnosis of Nonsmall Cell Lung Cancer and Chemotherapy Monitoring.
He X; Wang M
J Oncol; 2022; 2022():8800787. PubMed ID: 35368891
[TBL] [Abstract][Full Text] [Related]
20. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
